![Bob Löwenberg](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Bob Löwenberg
Gründer bei Frame Pharmaceuticals BV
Aktive Positionen von Bob Löwenberg
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Erasmus University Rotterdam | Corporate Officer/Principal | - | - |
The Royal Netherlands Academy of Arts & Sciences
![]() The Royal Netherlands Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Netherlands Academy of Arts & Sciences provides research services in the field of science and art. The private company is based in Amsterdam, Netherlands and has subsidiaries in Netherlands. The CEO of the Dutch company is Wilma de Koning. | Corporate Officer/Principal | - | - |
Frame Pharmaceuticals BV
![]() Frame Pharmaceuticals BV BiotechnologyHealth Technology Part of CureVac NV, Frame Pharmaceuticals BV is a Dutch company that offers cancer therapy services. The company is based in Amsterdam, Netherlands. The company was founded by Ronald Plasterk, Bob Löwenberg. Ronald Plasterk has been the CEO since incorporation. Frame Pharmaceuticals was acquired by CureVac NV on June 08, 2022 for $34.26 million. | Gründer | 27.12.2018 | - |
Vertrieb & Marketing | 27.12.2018 | - |
Karriereverlauf von Bob Löwenberg
Ehemalige bekannte Positionen von Bob Löwenberg
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Skyline Diagnostics BV
![]() Skyline Diagnostics BV Electronic Equipment/InstrumentsElectronic Technology Skyline Diagnostics develops and commercializes diagnostic microarrays for oncology. These tests currently provide the healthcare professional diagnostic information using one comprehensive test and may be useful in the clinical management of patients with cancer. Skyline Diagnostics products are currently available research only tools in the United States. The development pipeline includes diagnostic tests for Acute Myeloid Leukemia, Multiple Myeloma, Acute Lymphatic Leukemia, and Brain tumors. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2005 | 22.08.2013 |
Introgene BV | Corporate Officer/Principal | - | 23.10.2008 |
SkylineDx BV
![]() SkylineDx BV Medical/Nursing ServicesHealth Services SkylineDx BV develops molecular diagnostic tests for blood cancers. The firm focuses on the development and commercialization of gene signature-based diagnostic tests, which assist healthcare professionals in making personalized treatment decisions for individual patients. Its products include MMprofiler and AMLprofiler. The company was founded by Dharminder S. Chahal and Bob Löwenberg in 2005 and is headquartered in Rotterdam, the Netherlands. | Gründer | 01.01.2005 | - |
Ausbildung von Bob Löwenberg
University of Groningen | Graduate Degree |
Erasmus University Rotterdam | Doctorate Degree |
Statistik
International
Niederlande | 8 |
Operativ
Corporate Officer/Principal | 3 |
Founder | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Sektoral
Consumer Services | 3 |
Health Technology | 3 |
Electronic Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 5 |
---|---|
Skyline Diagnostics BV
![]() Skyline Diagnostics BV Electronic Equipment/InstrumentsElectronic Technology Skyline Diagnostics develops and commercializes diagnostic microarrays for oncology. These tests currently provide the healthcare professional diagnostic information using one comprehensive test and may be useful in the clinical management of patients with cancer. Skyline Diagnostics products are currently available research only tools in the United States. The development pipeline includes diagnostic tests for Acute Myeloid Leukemia, Multiple Myeloma, Acute Lymphatic Leukemia, and Brain tumors. | Electronic Technology |
The Royal Netherlands Academy of Arts & Sciences
![]() The Royal Netherlands Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Netherlands Academy of Arts & Sciences provides research services in the field of science and art. The private company is based in Amsterdam, Netherlands and has subsidiaries in Netherlands. The CEO of the Dutch company is Wilma de Koning. | Commercial Services |
Introgene BV | Health Technology |
SkylineDx BV
![]() SkylineDx BV Medical/Nursing ServicesHealth Services SkylineDx BV develops molecular diagnostic tests for blood cancers. The firm focuses on the development and commercialization of gene signature-based diagnostic tests, which assist healthcare professionals in making personalized treatment decisions for individual patients. Its products include MMprofiler and AMLprofiler. The company was founded by Dharminder S. Chahal and Bob Löwenberg in 2005 and is headquartered in Rotterdam, the Netherlands. | Health Services |
Frame Pharmaceuticals BV
![]() Frame Pharmaceuticals BV BiotechnologyHealth Technology Part of CureVac NV, Frame Pharmaceuticals BV is a Dutch company that offers cancer therapy services. The company is based in Amsterdam, Netherlands. The company was founded by Ronald Plasterk, Bob Löwenberg. Ronald Plasterk has been the CEO since incorporation. Frame Pharmaceuticals was acquired by CureVac NV on June 08, 2022 for $34.26 million. | Health Technology |
- Börse
- Insiders
- Bob Löwenberg
- Erfahrung